DE60039965D1 - Zusammensetzung zur erwerbung von immunologischer toleranz - Google Patents

Zusammensetzung zur erwerbung von immunologischer toleranz

Info

Publication number
DE60039965D1
DE60039965D1 DE60039965T DE60039965T DE60039965D1 DE 60039965 D1 DE60039965 D1 DE 60039965D1 DE 60039965 T DE60039965 T DE 60039965T DE 60039965 T DE60039965 T DE 60039965T DE 60039965 D1 DE60039965 D1 DE 60039965D1
Authority
DE
Germany
Prior art keywords
acquisition
composition
immunological tolerance
immunological
tolerance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60039965T
Other languages
English (en)
Inventor
Yousuke Takahama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Application granted granted Critical
Publication of DE60039965D1 publication Critical patent/DE60039965D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60039965T 1999-11-15 2000-09-19 Zusammensetzung zur erwerbung von immunologischer toleranz Expired - Lifetime DE60039965D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32477199A JP4552056B2 (ja) 1999-11-15 1999-11-15 後天的免疫寛容の獲得方法
PCT/JP2000/006379 WO2001035733A1 (fr) 1999-11-15 2000-09-19 Procede d'acquisition d'une tolerance immunologique

Publications (1)

Publication Number Publication Date
DE60039965D1 true DE60039965D1 (de) 2008-10-02

Family

ID=18169500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60039965T Expired - Lifetime DE60039965D1 (de) 1999-11-15 2000-09-19 Zusammensetzung zur erwerbung von immunologischer toleranz

Country Status (6)

Country Link
US (2) US7276234B1 (de)
EP (1) EP1142473B1 (de)
JP (1) JP4552056B2 (de)
CA (1) CA2360437C (de)
DE (1) DE60039965D1 (de)
WO (1) WO2001035733A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003047621A1 (ja) 2001-12-04 2005-04-14 中外製薬株式会社 抗ＰｅｐＴ抗体を含有する細胞増殖抑制剤
WO2003083116A1 (fr) 2002-03-29 2003-10-09 Chugai Seiyaku Kabushiki Kaisha Procede de criblage d'inhibiteurs de transporteurs
JP3785508B2 (ja) * 2002-04-15 2006-06-14 学校法人慶應義塾 遺伝子治療における免疫応答を解析できる実験モデルマウス
AU2003242024A1 (en) 2002-06-05 2003-12-22 Chugai Seiyaku Kabushiki Kaisha Method of constructing antibody
EP1403639A1 (de) * 2002-09-30 2004-03-31 G2M Cancer Drugs AG Antikörper als Diagnosemittel in der medizinischen Therapie mit Histondeacetylase-Hemmern
US7731960B2 (en) 2003-03-28 2010-06-08 Chugai Seiyaku Kabushiki Kaisha Antibodies that inhibit transport activity of peptide transporters
JP4846569B2 (ja) 2004-03-31 2011-12-28 中外製薬株式会社 抗体作製用非ヒト動物およびこれを用いた抗体作製方法およびシステム
EP1716751A1 (de) * 2005-04-28 2006-11-02 Veterinärmedizinische Universität Wien Tiermodelle für Zelltherapy und auf Zellen basierende Gentherapy
WO2011042181A1 (en) 2009-10-08 2011-04-14 Veterinärmedizinische Universität Wien Cell-tracking model system, transgenic for marker variants
EP2700945B1 (de) * 2011-04-22 2016-11-02 Kyoto University Verwendung des basischen myelinproteins als neuer genetischer faktor für rheumatoide arthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09187470A (ja) 1996-01-03 1997-07-22 Hidehiro Yamamoto ヒト以外の他動物にヒトの体組織を投与する事によっ て免疫寛容を導入した人工臓器
JPH09194393A (ja) 1996-01-22 1997-07-29 Meiji Milk Prod Co Ltd 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット
JPH10298101A (ja) 1997-04-28 1998-11-10 Dai Ichi Seiyaku Co Ltd 医薬製剤

Also Published As

Publication number Publication date
JP2001139496A (ja) 2001-05-22
CA2360437A1 (en) 2001-05-25
EP1142473A1 (de) 2001-10-10
EP1142473A4 (de) 2004-04-28
US20080010694A1 (en) 2008-01-10
US7276234B1 (en) 2007-10-02
EP1142473B1 (de) 2008-08-20
CA2360437C (en) 2009-02-24
US7671250B2 (en) 2010-03-02
WO2001035733A1 (fr) 2001-05-25
JP4552056B2 (ja) 2010-09-29

Similar Documents

Publication Publication Date Title
DE60017336D1 (de) Zusammensetzung zur Herstellung von Harzen
DE60007257D1 (de) Verfahren zur Herstellung von Cucurbituril Derivaten
IS6120A (is) Lyfjablanda
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69906389D1 (de) Verfahren zur herstellung von citalopram
DE69836091D1 (de) Verfahren zur herstellung von methanol
DE69912174D1 (de) Verfahren zur Herstellung von Dialkanolaminen
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE69943245D1 (de) Gaserzeugende zusammensetzung
AR025582A1 (es) Polipeptidos similares al factor de crecimiento de fibroblasto
DE60039965D1 (de) Zusammensetzung zur erwerbung von immunologischer toleranz
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE69935355D1 (de) Verfahren zur Herstellung von Citalopram
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
DE69812438T2 (de) Zusammensetzung zur herstellung von brennstoff-briketts
DE60031231D1 (de) Verfahren zur Herstellung von 2-Alkyl-4-Isothiazolin-3-onen
DE60004119D1 (de) Verfahren zur Herstellung von Pentaacetyl-beta-D-Glucopyranose
FI982378A0 (fi) Järjestely kohteen tutkimiseen
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
DE50003603D1 (de) Verfahren zur Herstellung von Bistrifluormethylbenzylaminen
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
ID27329A (id) Komposisi penghambat
DE60002513D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE50006464D1 (de) Verfahren zur Herstellung von Arylaminohydroxyanthrachinonen
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition